Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 71.67% is 12% below its 5-year average of 81.64%, around the middle of its 5-year range (59.58%–88.64%).
1.22% below its 12-month average of 72.56%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 73.45%.
GROSS MARGIN
71.67%
GROSS MARGIN AVG TTM
72.56%
GROSS MARGIN AVG 3Y
77.90%
GROSS MARGIN AVG 5Y
81.64%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.22%
CURRENT VS 3Y AVG
-8.00%
CURRENT VS 5Y AVG
-12.22%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.51%
median of 525 covered companies
CURRENT VS SECTOR MEDIAN
+54.10%
vs the sector median at left
Definitive Healthcare Corp.
Market Cap
$104.85M
Gross Margin
71.67%
TTM Avg
72.56%
3Y Avg
77.90%
5Y Avg
81.64%
Market Cap
$105.03M
Gross Margin
83.37%
TTM Avg
83.81%
3Y Avg
82.64%
5Y Avg
80.50%
Market Cap
$108.20M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.35%
Market Cap
$99.48M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
5.83%
5Y Avg
8.02%
Market Cap
$110.75M
Gross Margin
33.94%
TTM Avg
48.53%
3Y Avg
56.75%
5Y Avg
59.91%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definitive Healthcare Corp. (DH) | $104.85M | 71.67% | 72.56% | 77.90% | 81.64% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $105.03M | 83.37% | 83.81% | 82.64% | 80.50% |
| The Joint Corp. (JYNT)vs › | $102.66M | 81.08% | 78.73% | 81.53% | 84.24% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.20M | 0.00% | 0.00% | 0.00% | 2.35% |
| Immunic, Inc. (IMUX)vs › | $108.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Korro Bio, Inc. (KRRO)vs › | $100.55M | 33.04% | 66.52% | 33.26% | 38.13% |
| Anixa Biosciences, Inc. (ANIX)vs › | $99.48M | 0.00% | 0.00% | 5.83% | 8.02% |
| Apyx Medical Corporation (APYX)vs › | $110.75M | 33.94% | 48.53% | 56.75% | 59.91% |
| BGM Group Ltd. (BGM)vs › | $111.78M | 12.79% | 14.59% | 10.64% | 11.25% |
| Lucid Diagnostics Inc. (LUCD)vs › | $111.89M | -60.26% | -75.23% | -314.56% | -212.54% |
Gross Margin
71.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 73.45% |
| 2026-03-31 | 59.58% |
| 2025-12-31 | 68.13% |
| 2025-09-30 | 84.90% |
| 2025-06-30 | 76.73% |
| 2025-03-31 | 73.93% |
| 2024-12-31 | 76.42% |
| 2024-09-30 | 78.20% |
| 2024-06-30 | 79.16% |
| 2024-03-31 | 79.37% |
| 2023-12-31 | 81.02% |
| 2023-09-30 | 81.79% |
| 2023-06-30 | 81.68% |
| 2023-03-31 | 79.89% |
| 2022-12-31 | 88.20% |
| 2022-09-30 | 88.55% |
| 2022-06-30 | 88.64% |
| 2022-03-31 | 88.13% |
| 2021-12-31 | 88.07% |
| 2021-09-30 | 88.10% |
| 2021-09-17 | 88.52% |
| 2021-03-31 | 88.64% |
| 2020-12-31 | 90.47% |
| 2020-09-30 | 75.35% |
| 2020-06-30 | 90.37% |
| 2020-03-31 | 90.37% |
